Primary central nervous system lymphoma: Evolving treatment strategies to achieve improved long-term disease control
Journal of Oncology Pharmacy Practice
Published online on March 17, 2026
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
ObjectiveDespite high initial response rates to chemotherapy, long-term disease control in primary central nervous system lymphoma (PCNSL) remains challenging, with high relapse rates and no universally accepted standard for induction or consolidation ...
ObjectiveDespite high initial response rates to chemotherapy, long-term disease control in primary central nervous system lymphoma (PCNSL) remains challenging, with high relapse rates and no universally accepted standard for induction or consolidation ...